Emtricitabine and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Emtricitabine (emtricitabine), especially for people who are male, 30-39 old, have been taking the drug for 6 - 12 months also take Darunavir, and have Hiv infection.

The phase IV clinical study analyzes which people have Heart attack when taking Emtricitabine. It is created by eHealthMe based on reports of 6,373 people who have side effects when taking Emtricitabine from the FDA, and is updated regularly.

What is Emtricitabine?

Emtricitabine has active ingredients of emtricitabine. eHealthMe is studying from 6,391 Emtricitabine users. Check the latest studies of Emtricitabine.

What is Heart attack?

Heart attack is found to be associated with 2,484 drugs and 3,296 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 12, 2026

6,373 people reported to have side effects when taking Emtricitabine.
Among them, 77 people (1.21%) have Heart attack.

Among these 77 people:

How long have people been on Emtricitabine when they have Heart attack? *

What is the gender of people who have Heart attack when taking Emtricitabine? *

female: 16.13 %
male: 83.87 %

What is the age of people who have Heart attack when taking Emtricitabine? *

What are other drugs people take besides Emtricitabine? *

Darunavir: 43 people, 55.84%
Lamivudine: 29 people, 37.66%
Ritonavir: 26 people, 33.77%
Atazanavir: 24 people, 31.17%
Abacavir: 24 people, 31.17%
Viread: 23 people, 29.87%
Emtriva: 22 people, 28.57%
Zidovudine: 15 people, 19.48%
Tenofovir Disoproxil Fumarate: 14 people, 18.18%
Raltegravir: 14 people, 18.18%

What are other side effects people have besides Heart attack? *

Coronary Heart Disease (narrowing or blockage of the coronary arteries): 29 people, 37.66%
Hypertriglyceridaemia (excess of triglycerides in the blood): 15 people, 19.48%
Acute Myocardial Infarction (acute heart attack): 13 people, 16.88%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 11 people, 14.29%
Drug Resistance (reduction in effectiveness of a drug): 10 people, 12.99%
Adverse Event: 10 people, 12.99%
Depression: 9 people, 11.69%
Chest Pain: 9 people, 11.69%
Anaemia (lack of blood): 7 people, 9.09%
Pathogen Resistance: 7 people, 9.09%

What are the existing conditions these people have? *

Hiv Infection: 57 people, 74.03%
Hypertriglyceridaemia (excess of triglycerides in the blood): 24 people, 31.17%
Neuropathy Peripheral (surface nerve damage): 11 people, 14.29%
Diabetes: 11 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 14.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 11 people, 14.29%
High Blood Pressure: 7 people, 9.09%
Headache (pain in head): 7 people, 9.09%
Dyslipidaemia (abnormal amount of lipids): 3 people, 3.90%
Oral Candidiasis (fungal infection of mouth): 3 people, 3.90%

* Approximation only. Some reports may have incomplete information.

Do you take Emtricitabine and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emtricitabine:

Emtricitabine (6,391 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Emtricitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,484 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,296 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emtricitabine (the active ingredients of Emtricitabine) and Emtricitabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.